-
-
-
-
-
-
-
Gilead Sciences completes $7.8 billion Arcellx acquisition
-
-
-
-
-
-
-
Barclays launches U.S. biopharma coverage with four preferred picks
-
-
-
-
-
-
-
Gilead Sciences (GILD) PT Raised to $146 at Leerink Partners
-
-
-
-
-
-
-
Where can biotech stocks go from here? RBC answers
-
-
-
-
-
-
-
Gilead partners with PEPFAR to deliver HIV prevention drug to 2 million people
-
-
-
-
-
-
-
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
-
-
-
-
-
-
-
Gilead Sciences (GILD) Yeztugo Label 'Looks Clean' - Mizuho
-
1,211,619 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

